NURS 6521 AACC Pharmacotherapy for Cardiovascular Disorders Essay

User Generated

ww6800

Health Medical

NURS 6521

Anne Arundel Community College

NURS

Description

.heart disease remains the No. 1 killer in America; nearly half of all Americans have high blood pressure, high cholesterol, or smoke—some of the leading risk factors for heart disease…

—Murphy et al., 2018

Despite the high mortality rates associated with cardiovascular disorders, improved treatment options do exist that can help address those risk factors that afflict the majority of the population today.  

Photo Credit: Getty Images/Science Photo Library RF

As an advanced practice nurse, it is your responsibility to recommend appropriate treatment options for patients with cardiovascular disorders. To ensure the safety and effectiveness of drug therapy, advanced practice nurses must consider aspects that might influence pharmacokinetic and pharmacodynamic processes such as medical history, other drugs currently prescribed, and individual patient factors.

Reference: Murphy, S. L., Xu, J., Kochanek, K. D., & Arias, E. (2018). Mortality in the United States, 2017. Retrieved from https://www.cdc.gov/nchs/products/databriefs/db328...

To Prepare

Review the Resources for this module and consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece.

Review the case study assigned by your Instructor for this Assignment.

Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.

Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.

Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.

Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.

By Day 7 of Week 2

  • Write a 2- to 3-page paper that addresses the following:
  • Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.
  • Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
  • Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements.

This week, you will examine the impact of patient factors that may lead to changes in pharmacokinetic and pharmacodynamic processes on patient drug therapy for cardiovascular disorders. You will also explore ways to improve drug therapy plans for cardiovascular disorders based on patient factors and overall health needs.

Students will:

  • Analyze the influence of patient factors on pharmacokinetic and pharmacodynamic processes
  • Analyze the impact of changes in pharmacokinetic and pharmacodynamic processes on patient drug therapies
  • Evaluate drug therapy plans for cardiovascular disorders

Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:

  • Glipizide 10 mg po daily
  • HCTZ 25 mg daily
  • Atenolol 25 mg po daily
  • Hydralazine 25 mg qid
  • Simvastatin 80 mg daily
  • Verapamil 180 mg CD daily

Unformatted Attachment Preview

Rubric Detail Select Grid View or List View to change the rubric's layout. Name: NURS_6521_Week2_Assignment_Rubric Grid View EXIT List View Excellent Good Fair Poor Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned. 23 (23%) - 25 (25%) 20 (20%) - 22 (22%) 18 (18%) - 19 (19%) 0 (0%) - 17 (17%) The response accurately and completely explains in detail how the factor selected might influence the pharmacokinetic and pharmacodynamic processes in the patient. The response provides a basic explanation of how the factor selected might influence the pharmacokinetic and pharmacodynamic processes in the patient. The response inaccurately or vaguely explains how the factor selected might influence the pharmacokinetic and pharmacodynamic processes in the patient. The response inaccurately and vaguely explains how the factor selected might influence the pharmacokinetic and pharmacodynamic processes in the patient, or is missing. Describe how changes in the processes might impact the patient's recommended drug therapy. Be specific and provide examples. 27 (27%) - 30 (30%) 24 (24%) - 26 (26%) 21 (21%) - 23 (23%) 0 (0%) - 20 (20%) The response accurately and completely describes in detail how changes in the processes might impact the patient's recommended drug therapy. The response accurately describes how changes in the processes might impact the patient's recommended drug therapy. The response inaccurately or vaguely describes how changes in the processes might impact the patient's recommended drug therapy. Accurate examples may be provided to support the response. Inaccurate or vague examples are provided to support the response. The response inaccurately and vaguely describes how changes in the processes might impact the patient's recommended drug therapy, or is missing. 27 (27%) - 30 (30%) 24 (24%) - 26 (26%) 21 (21%) - 23 (23%) 0 (0%) - 20 (20%) The response accurately and clearly explains in detail how to improve the patient's drug The response accurately explains how to improve the patient's drug therapy plan. The response inaccurately or vaguely explains how to improve the patient's drug therapy plan. The response inaccurately and vaguely explains how to improve the patient's drug therapy plan, or is Accurate, complete, and aligned examples are provided to support the response. Explain how you might improve the patient's drug therapy plan, and explain why you would make these recommended Inaccurate and vague examples may be provided to support the response, or is missing. improvements. therapy plan. The response includes an accurate and detailed explanation to support the recommended improvements. The response may include an accurate explanation to support the recommended improvements. The response may include an inaccurate, vague, or misaligned explanation to support the recommended improvements. 3.5 (3.5%) - 3.5 Written Expression and Formatting Paragraph Development and Organization: Paragraphs make clear points that support well developed ideas, flow logically, and demonstrate continuity of ideas. Sentences are carefully focused--neither long and rambling nor short and lacking substance. 5 (5%) - 5 (5%) 4 (4%) - 4 (4%) Paragraphs and sentences follow writing standards for flow, continuity, and clarity. Paragraphs and sentences follow writing standards for flow, continuity, and clarity 80% of the time. (3.5%) Written Expression and Formatting English writing standards: Correct grammar, mechanics, and proper punctuation 5 (5%) - 5 (5%) 4 (4%) - 4 (4%) 3.5 (3.5%) - 3.5 Uses correct grammar, spelling, and punctuation with no errors Contains a few (1– 2) grammar, spelling, and punctuation errors (3.5%) Written Expression and Formatting - The paper follows correct APA format for title page, headings, font, spacing, margins, indentations, page numbers, running head, parenthetical/intext citations, and reference list. 5 (5%) - 5 (5%) 4 (4%) - 4 (4%) 3.5 (3.5%) - 3.5 Uses correct APA format with no errors Contains a few (1– 2) APA format errors Paragraphs and sentences follow writing standards for flow, continuity, and clarity 60%–79% of the time. Contains several (3–4) grammar, spelling, and punctuation errors (3.5%) Contains several (3–4) APA format errors missing. The response may include an inaccurate and vague explanation to support the recommended improvements, or is missing. 0 (0%) - 3 (3%) Paragraphs and sentences follow writing standards for flow, continuity, and clarity less than 60% of the time. 0 (0%) - 3 (3%) Contains many (≥ 5) grammar, spelling, and punctuation errors that interfere with the reader’s understanding 0 (0%) - 3 (3%) Contains many (≥ 5) APA format errors Total Points: 100 Name: NURS_6521_Week2_Assignment_Rubric EXIT
Purchase answer to see full attachment
User generated content is uploaded by users for the purposes of learning and should be used following Studypool's honor code & terms of service.

Explanation & Answer

View attached explanation and answer. Let me know if you have any questions.

Pharmacotherapy for Cardiovascular Disorders Outline
Thesis statement: In the United States, Diabetes is the 7thleading cause of death that is usually
linked with comorbidities like stroke, heart attack, kidney disease, hypertension, and
cardiovascular disease. Notably, in this case study my patient will be aged 63 years and will be
an African-American.


Ethnicity as the factor that influence the pharmacokinetic and pharmacodynamics process
in the patient from the case study.



The various ways the changes might affect the patient’s recommended drug therapy.



The various ways I might improve the patient’s drug therapy plan and my explanations
why I would make these recommended improvements.


1

Pharmacotherapy for Cardiovascular Disorders

Name
Professor
Institution
Course

2

Pharmacotherapy for Cardiovascular Disorders
In the United States, Diabetes is the 7thleading cause of death that is usually linked with
comorbidities like stroke, heart attack, kidney disease, hypertension, and cardiovascular disease.
It is worth noting that Africans-Americans have a higher probability of obesity, stroke,
cardiovascular disease, and hypertension than other ethnicit...

Related Tags